| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 18,594 | 20,356 | 17,994 | 16,413 | | Cost of Revenue | 2,938 | 3,214 | 3,367 | 3,022 | | | Gross Profit |
-
| 17,142 | 14,627 | 13,391 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 10,077 | 11,501 | 10,401 | 8,506 | | Non Recurring | 944 | 814 |
-
|
-
| | Others | 3,825 | 2,236 | 5,445 | 1,412 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 2,591 | (1,219) | 3,473 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 810 | 2,591 | (1,219) | 3,473 | | Interest Expense | 1,894 | 1,941 | 2,042 | 2,141 | | Income Before Tax | (1,084) | 650 | (3,261) | 1,332 | | Income Tax Expense | (948) | 433 | (1,383) | 200 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (136) | 217 | (1,878) | 1,132 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (136) | 217 | (1,878) | 1,132 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($136) | $217 | ($1,878) | $1,132 |
|
0.26% Nasdaq 0.00%
Income Statement
